Eaton Vance Management Verastem, Inc. Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Verastem, Inc. stock. As of the latest transaction made, Eaton Vance Management holds 20,000 shares of VSTM stock, worth $59,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$59,600
Previous $23,000
26.09%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VSTM
# of Institutions
5Shares Held
297KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY225KShares$670,5000.14% of portfolio
-
Beaumont Financial Partners, LLC48KShares$143,0400.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.99KShares$8,8950.0% of portfolio
-
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L21.07KShares$3,2000.0% of portfolio
About Verastem, Inc.
- Ticker VSTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 210,000,000
- Market Cap $626M
- Description
- Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...